A focused group of Robinson Bradshaw lawyers is dedicated to representing life sciences clients at every stage of a company's life cycle, including in such core areas such as IP development, protection and maintenance, start-up and structuring, debt and equity capital raising (for both investors and companies), technology transfer and licensing, regulatory compliance, manufacturing and commercial contracts, and mergers and acquisitions.
The life sciences practice group also integrates our Robinson Bradshaw colleagues for additional experience in federal and state tax, intellectual property, economic development and incentives, employment law, executive compensation, litigation (including IP litigation), public finance, real estate, ERISA and public securities offerings.
Our life sciences clients span a variety of industries including genetics and genomics, pharmaceutical, biotechnology, personalized health care services, medical diagnostics, and food and nutritional supplements. Representative clients include: a leading pharma-focused private equity fund and other life sciences investors; an international leader in nephrology therapies and services; pioneering research entities including the Personal Genome Project and regional universities; significant developers and manufacturers of pharmaceutical, nutraceutical and nutritional products; and the largest regional and university hospital systems.